Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record now shows 'No longer looking for participants', indicating termination due to poor accrual and no further enrollment. Additionally, the page adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision stamp from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check18 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a minor update to the page’s documentation. The core study details, eligibility criteria, and results information appear unchanged.SummaryDifference0.0%

- Check40 days agoChange DetectedThe revision tag v3.5.4 was added and the previous v3.5.3 was removed. This reflects a backend/content update to the page's revision history.SummaryDifference0.0%

- Check47 days agoChange DetectedBranding elements referencing Mayo Clinic (the Mayo Clinic web site, Mayo Clinic, and the 'Helpful Links Provided by Mayo Clinic' blocks) were removed from the page.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page’s footer revision/version indicator was incremented from **v3.5.2** to **v3.5.3**, reflecting a site/record interface update rather than a change to the clinical trial details.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.